Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$620K Buy
19,810
+1,617
+9% +$46.7K 0.27% 87
2026
Q2
$399K Buy
18,193
+5,395
+42% +$119K 0.18% 134
2026
Q1
$246K Buy
+12,798
New +$249K 0.13% 172
2025
Q1
– Sell
-4,349
Closed -$141K – 340
2024
Q4
$141K Buy
4,349
+493
+13% +$17.7K 0.08% 222
2024
Q3
$138K Buy
3,856
+289
+8% +$10.2K 0.08% 200
2024
Q2
$125K Sell
3,567
-646
-15% -$20.5K 0.07% 217
2024
Q1
$127K Buy
4,213
+1,200
+40% +$35.3K 0.07% 233
2023
Q4
$90.7K Sell
3,013
-3
-0.1% -$84 0.06% 220
2023
Q3
$77.5K Sell
3,016
-35
-1% -$1.07K 0.07% 203
2023
Q2
$93.7K Sell
3,051
-2,216
-42% -$66.5K 0.08% 191
2023
Q1
$155K Buy
5,267
+61
+1% +$1.75K 0.14% 142
2022
Q4
$140K Sell
5,206
-1,486
-22% -$41.1K 0.14% 140
2022
Q3
$167K Sell
6,692
-4,691
-41% -$144K 0.16% 138
2022
Q2
$180K Buy
11,383
+3,797
+50% +$139K 0.14% 153
2022
Q1
$275K Buy
+7,586
New +$280K 0.17% 125
2021
Q2
$188K Buy
+6,240
New +$199K 0.08% 217

Other funds holding HPQ

Castleview Partners's HPQ Position: Q3 2026 in Review

Castleview Partners increased its HP (HPQ) stake by 8.9% in Q3 2026, buying an estimated $46.7K and bringing the position to 19,810 shares worth $620K. The position accounts for 0.27% of the portfolio, ranked #87.

Castleview Partners first reported a position in HPQ in Q2 2021 and has held it in 16 quarters since. 48 funds tracked by Wall St. Rank hold HPQ as of Q3 2026.

  • Castleview Partners held 19,810 shares of HP worth $620K as of Q3 2026.
  • Castleview Partners bought 1,617 HP shares in Q3 2026, an estimated $46.7K.
  • HP made up 0.27% of Castleview Partners's portfolio in Q3 2026, its #87 holding.
  • Castleview Partners first reported a position in HP in Q2 2021 and has held it in 16 quarters since.
  • 48 funds tracked by Wall St. Rank held HP as of Q3 2026.

Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.